Deletion of TP53I11 promotes AKT/m-TOR and AMPK pathways, respectively, subsequently reducing m-TOR activation and consequently maintaining energy homeostasis in BC cells [214], promoting cell survival after ECM isolation. Here, AKT1 is linked to breast cancer.